Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

EMDT, MD+DI, and Qmed Announce Virtual Event Dedicated to Developments in Materials for Medical Applications

March 22, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, March 22, 2011 /- UBM Canon's Medical Device Media Group today announced its leading brands, EMDT ( European Medical Device Technology ), MD+DI ( Medical Device & Diagnostic Industry ), and Qmed, the world's only 100% qualified medical device supplier directory and search...

TOPICS:

FDA bars Michigan firm from selling heart machines

March 22, 2011 8:45 am | by The Associated Press | News | Comments

The federal government is legally barring a Michigan company from selling life-sustaining devices used in heart surgery, following years of quality control problems at company facilities.The Food and Drug Administration said Tuesday it signed a permanent injunction with Terumo Cardiovascular...

BGI joins Earth Microbiome Project

March 22, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

BGI, a Chinese institute with ties to Cambridge researchers, has joined the Earth Microbiome Project, a global effort to determine the functional and evolutionary diversity of microbial communities on the planet.

Advertisement

Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives

March 22, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., March 22, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug...

TOPICS:

Manufacturing Experts Provide Keys to Success at EASTEC 2011 Resource Center Presentations

March 22, 2011 7:34 am | by Society of Manufacturing Engineers | News | Comments

WEST SPRINGFIELD, MA (March 22, 2011) — CNC Software, Inc., an EASTEC 2011 exhibitor that provides state-of-the-art software tools for CAD/CAM manufacturing markets, intends to let its resellers, customers, and prospects know about its plans for the event. While that may seem no...

Tesaro buys rights to Amgen lung cancer tech program

March 22, 2011 7:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston cancer-focused biotech startup Tesaro Inc. has landed an exclusive licensing deal with Amgen Inc., in which the Boston company will hold rights to Amgen's Anaplastic Lymphoma Kinase (ALK) technology.

Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board

March 22, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, March 22, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced the appointment of  J. Michael Pearson, currently Valeant's Chief Executive Officer (CEO), as Chairman of the Board of Directors, replacing Robert A. Ingram,...

TOPICS:

Dental Bib Chains are Potential Source for Infection and Disease

March 22, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., March 22, 2011 /- Wet, used towels left in the gym. Dirty tissues discarded by someone suffering from a nasty cold. A toothbrush discovered in a hotel room. Most of us would never use or even touch these items. But without knowing it, we may be sharing something that...

TOPICS:
Advertisement

Cinryze® (C1 Esterase Inhibitor Human) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting

March 22, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., March 22, 2011 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced data presented in two poster presentations relating to Cinryze® (C1 esterase inhibitor [human]) at the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, March 18...

TOPICS:

FDA: Michigan Heart-Lung Bypass Machine Manufacturer Enters Into Consent Decree

March 22, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 22, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that Terumo Cardiovascular Systems Corporation (TCVS) of Ann Arbor, Mich., and two of its officers, Mark A. Sutter, president and chief executive officer, and Mark Lincoln,...

TOPICS:

Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR

March 22, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., March 22, 2011 /- Later this month, Quest Diagnostics (NYSE: DGX ) will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360™ EHR . The 12-week, 10-city Care360 EHR Road Test tour was developed to help hospitals and...

TOPICS:

Instrumentation Laboratory Achieves Record Sales in 2010

March 22, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., March 22, 2011 /- Instrumentation Laboratory (IL) today announced total worldwide sales in 2010 of Euro 474.2 million ($644.9 million US). This represents 11.5% growth v. previous year in current, and 10.3% in local currencies.  In the Company's two major business...

TOPICS:

Labopharm cuts nearly 30 per cent of its workforce to reduce operating costs

March 22, 2011 5:45 am | by The Associated Press | News | Comments

Montreal-area drug developer Labopharm Inc. (TSX:DDS) is eliminating 38 positions, or nearly 30 per cent of its current workforce. The workforce reduction is expected to result in $3.8 million per year in savings.

Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule

March 22, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., March 22, 2011 /- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCell® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of...

TOPICS:

GeNO LLC Initiates Study of Inhaled NITROSYLâ„¢ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients

March 22, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

COCOA, Fla., March 22, 2011 /- GeNO LLC ( www.genollc.com ), a privately held, advanced development-stage technology company, today announced commencement of  the PHiano Study: A Phase 2, Dose-Escalation Trial for the Treatment of Pulmonary Hypertension in patients with Pulmonary...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading